Amyloid ß and Tau Oligomers Disrupt Blood-Brain Barrier in a Human Based in-vitro Microfluidic Neurovascular Unit Model

Accuracy of Plasma Biomarkers for Detecting Amyloid Beta Deposits in Participants With Alzheimer’s Disease in ASCENT-2 Clinical Trial of PRX012

CSF YKL-40 Level Predicts the Cognitive Progress of De Novo Parkinson’s Disease

Diagnostic Utility of 18F-Florzolotau PET Imaging in Patients with Cognitive Symptoms: A Real-World Cohort Study

Multiplex Cerebrospinal Fluid Proteomics Identifies Biomarkers for Diagnosis and Prediction of Alzheimer's Disease